Stay updated on SHP2 Inhibitor BBP-398 Clinical Trial
Sign up to get notified when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.

Latest updates to the SHP2 Inhibitor BBP-398 Clinical Trial page
- Check7 days agoChange DetectedA consolidated Locations section has been added listing Alabama, California, Colorado, Texas, Utah, Virginia, and Washington under a single header, replacing the previous separate location blocks. The page shows Revision: v3.3.3, and older items like HHS Vulnerability Disclosure and individual state location blocks have been removed.SummaryDifference0.9%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check42 days agoChange DetectedRemoved the government funding lapse notice and operating status information visible on the page. Core trial details, inclusion criteria, and study results remain unchanged.SummaryDifference0.4%

- Check56 days agoChange DetectedBetween the old and new screenshots, core study details such as status, enrollment, locations, and outcomes appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check85 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference5%

- Check92 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

Stay in the know with updates to SHP2 Inhibitor BBP-398 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.